Excelsior Medical Co (TPE:4104) Cyclically Adjusted Revenue per Share: NT$50.60 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4104 Excelsior Medical Co Ltd TPE:4104
87 GF Score
Price NT$70.00
GF Value NT$87.68
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Excelsior Medical Co Cyclically Adjusted Revenue per Share?

Excelsior Medical Co TPE:4104 -1.13% 87 Cyclically Adjusted Revenue per Share is NT$50.60 as of Mar. 2026. GuruFocus rates TPE:4104 with a GF Score™ of 87/100 and a GF Value™ of NT$87.68 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Excelsior Medical Co's adjusted revenue per share for the three months ended in Mar. 2026 was NT$12.749. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$50.60 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Excelsior Medical Co's average Cyclically Adjusted Revenue Growth Rate was 2.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 1.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Excelsior Medical Co was 3.70% per year. The lowest was 1.90% per year. And the median was 2.50% per year.

As of today (2026-08-03), Excelsior Medical Co's current stock price is NT$70.00. Excelsior Medical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was NT$50.60. Excelsior Medical Co's Cyclically Adjusted PS Ratio of today is 1.38.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Excelsior Medical Co was 1.80. The lowest was 0.90. And the median was 1.37.


Excelsior Medical Co  (TPE:4104) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Excelsior Medical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=70.00/50.60
=1.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Excelsior Medical Co was 1.80. The lowest was 0.90. And the median was 1.37.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Excelsior Medical Co Cyclically Adjusted Revenue per Share Related Terms


Excelsior Medical Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Excelsior Medical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Excelsior Medical Co Cyclically Adjusted Revenue per Share Chart

Excelsior Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.28 47.01 48.15 48.98 49.67

Excelsior Medical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.51 49.69 49.81 49.67 50.60

TPE:4104 vs MCK, COR, CAH: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Excelsior Medical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Excelsior Medical Co Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Excelsior Medical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Excelsior Medical Co's Cyclically Adjusted PS Ratio falls into.


TPE:4104
87GF Score
Excelsior Medical Co Ltd TPE:4104
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Excelsior Medical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Excelsior Medical Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=12.749/330.2130*330.2130
=12.749

Current CPI (Mar. 2026) = 330.2130.

Excelsior Medical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 9.687 241.018 13.272
201609 9.675 241.428 13.233
201612 9.983 241.432 13.654
201703 9.237 243.801 12.511
201706 9.476 244.955 12.774
201709 9.440 246.819 12.630
201712 9.751 246.524 13.061
201803 9.645 249.554 12.762
201806 9.792 251.989 12.832
201809 9.909 252.439 12.962
201812 10.606 251.233 13.940
201903 10.035 254.202 13.036
201906 9.766 256.143 12.590
201909 10.120 256.759 13.015
201912 10.678 256.974 13.721
202003 10.033 258.115 12.835
202006 9.144 257.797 11.713
202009 9.644 260.280 12.235
202012 9.501 260.474 12.045
202103 9.298 264.877 11.591
202106 8.999 271.696 10.937
202109 9.012 274.310 10.849
202112 12.551 278.802 14.865
202203 9.749 287.504 11.197
202206 9.539 296.311 10.630
202209 10.508 296.808 11.691
202212 11.181 296.797 12.440
202303 11.457 301.836 12.534
202306 11.570 305.109 12.522
202309 11.559 307.789 12.401
202312 12.452 306.746 13.405
202403 11.669 312.332 12.337
202406 12.391 314.175 13.024
202409 11.786 315.301 12.343
202412 12.980 315.605 13.581
202503 12.894 319.799 13.314
202506 12.456 322.561 12.751
202509 12.570 324.800 12.779
202512 12.986 324.054 13.233
202603 12.749 330.213 12.749

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$50.60 mean?
Excelsior Medical Co (TPE:4104) has a Cyclically Adjusted Revenue per Share of NT$50.60 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Excelsior Medical Co and its competitors.
Is Excelsior Medical Co's Cyclically Adjusted Revenue per Share too high?
Excelsior Medical Co's current Cyclically Adjusted Revenue per Share is NT$50.60. Overall, Excelsior Medical Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Excelsior Medical Co's Cyclically Adjusted Revenue per Share compare to MCK and COR?
Excelsior Medical Co's Cyclically Adjusted Revenue per Share of NT$50.60 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Excelsior Medical Co and its competitors. Excelsior Medical Co's current Cyclically Adjusted Revenue per Share is NT$50.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Excelsior Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Excelsior Medical Co (TPE:4104) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.68, compared to a current price of NT$70.00 — trading 20.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$50.60. Excelsior Medical Co's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Excelsior Medical Co (TPE:4104), the current Cyclically Adjusted Revenue per Share is NT$50.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Excelsior Medical Co (TPE:4104) Overvalued in 2026?

Based on GuruFocus' analysis, Excelsior Medical Co stock appears to be undervalued. The current stock price of NT$70.00 is trading 20.2% below its estimated GF Value™ of NT$87.68. GuruFocus considers Excelsior Medical Co to be Modestly Undervalued.

Key valuation signals for TPE:4104:

  • Cyclically Adjusted Revenue per Share: NT$50.60
  • GF Value™: NT$87.68 vs. price of NT$70.00 (20.2% below fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the TPE:4104 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Excelsior Medical Co Business Description

Address Zhongzheng Road, No. 880, 17th Floor, Zhonghe District, New Taipei City, TWN, 235
Excelsior Medical Co Ltd is engaged in the sale of medical supplies and medicines, home medical devices, and medical equipment with brand names of local and foreign manufacturers. Its product offerings include Fasflo hollow fiber dialyzer, Renabio sodium chloride injection, acid concentrates, Sunder blood purification tubing set, JMS blood bags, etc. The Group's reportable segments include Excelsior, Dynamic, Arich, and Others. Maximum revenue is generated from the Excelsior segment. Geographically, it derives key revenue from Taiwan and also has a presence in Hong Kong, China, the Philippines, Malaysia, and Indonesia.
87GF Score

Get the complete analysis for TPE:4104

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$70.00
Price
NT$87.68
GF Value